We use cookies to help provide you with the best possible online experience. Please read our Privacy Policy for information about which cookies we use and what information we collect on our site. By continuing to use this site, you agree that we may store and access cookies on your device.
Insilico Medicine, a global leader in end-to-end AI-powered drug discovery, announced the appointment of Steven Galson, MD, MPH as the independent member of the board of directors.